Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quillet

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cellular Immunology|April 1, 1994
Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cellsS Lebel-Binay, M L Gil, C Lagaudriere, et al.
Leukemia|September 10, 2010
B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cellsE Gross, F-E L'Faqihi-Olive, L Ysebaert, et al.
Cancer Investigation|January 26, 2011
Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profilingJames R Hocker, Megan R Lerner, Stephanie L Mitchell, et al.
Cancer Investigation|September 27, 2017
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer PatientsJames R Hocker, Subrato J Deb, Min Li, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cellular Immunology|April 1, 1994
Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cellsS Lebel-Binay, M L Gil, C Lagaudriere, et al.
Leukemia|September 10, 2010
B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cellsE Gross, F-E L'Faqihi-Olive, L Ysebaert, et al.
Cancer Investigation|January 26, 2011
Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profilingJames R Hocker, Megan R Lerner, Stephanie L Mitchell, et al.
Cancer Investigation|September 27, 2017
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer PatientsJames R Hocker, Subrato J Deb, Min Li, et al.
Pageof 3